# A Controlled Study to Evaluate the Efficacy of Allogeneic MesenCure for the Treatment of Patients With ARDS

> **NCT05497401** · PHASE3 · NOT_YET_RECRUITING · sponsor: **BonusBio Group Ltd** · enrollment: 300 (estimated)

## Conditions studied

- ARDS

## Interventions

- **BIOLOGICAL:** MesenCure
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05497401
- **Lead sponsor:** BonusBio Group Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-06
- **Final completion:** 2028-10
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05497401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05497401, "A Controlled Study to Evaluate the Efficacy of Allogeneic MesenCure for the Treatment of Patients With ARDS". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05497401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*